In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel
Authors:
- 1 October 2003
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 92 (3) , 301-313
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Part I: Chemotherapy for epithelial ovarian cancer–treatment at first diagnosisThe Lancet Oncology, 2002
- Surgical quality in trials of adjuvant cancer therapyJournal of Surgical Oncology, 2002
- Cisplatin‐incorporated Polymeric Micelles Eliminate Nephrotoxicity, While Maintaining Antitumor ActivityJapanese Journal of Cancer Research, 2001
- Skull bone regeneration in primates in response to basic fibroblast growth factorJournal of Neurosurgery, 1999
- Intraperitoneal chemotherapyCritical Reviews in Oncology/Hematology, 1999
- Design and testing of a new cisplatin form using a base material by combining poly-D,L-lactic acid and polyethylene glycol acid against peritoneal metastasisInternational Journal of Cancer, 1998
- In vivo suppressive effects of copoly(glycolic/L-lactic acid) microspheres containing CDDP on murine tumor cellsJournal of Controlled Release, 1996
- Antitumor activity of cis-diamminedichloroplatinum II against human tumor xenografts depends on its area under the curve in nude miceJournal of Surgical Oncology, 1996
- Intratumoral ChemotherapyNeurosurgery, 1995
- Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogelsJournal of Controlled Release, 1994